Akebia Therapeutics Inc (NAS:AKBA)
$ 1.705 0.08 (4.91%) Market Cap: 358.54 Mil Enterprise Value: 352.78 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q2 2022 Akebia Therapeutics Inc Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT
Release Date Price: $0.41 (+4.99%)
Operator

Hello, and welcome to the Akebia Second Quarter 2022 Financial Results. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Mercedes Carrasco, Senior Director of Corporate Communications. Please go ahead.

Mercedes Carrasco
Akebia Therapeutics, Inc. - Director of Corporate Communications

Thank you, and welcome to Akebia's Second Quarter 2022 Financial Results and Business Update Conference Call. Please note that a press release was issued earlier today, Thursday, August 4, detailing our second quarter financial results, and that release is available on our Investors section of our website. For your convenience, a replay of today's call will also be available on our website shortly after we conclude. Joining me for today's call, we have John Butler, Chief Executive Officer; Steve Burke, Chief Medical Officer; and Dave Spellman, Chief Financial Officer.

Before we begin, I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement on this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot